Long-term efficacy and safety of biphasic insulin aspart in patients with type 2 diabetes

European Journal of Internal Medicine ◽

10.1016/j.ejim.2004.10.001 ◽

2004 ◽

Vol 15 (8) ◽

pp. 496-502 ◽

Author(s):

Bernhard O. Boehm ◽

Julius A. Vaz ◽

Lise Brøndsted ◽

Philip D. Home

Keyword(s):

Type 2 Diabetes ◽

Insulin Aspart ◽

Efficacy And Safety ◽

Term Efficacy ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin

Download Full-text

Therapy conversion to biphasic insulin aspart 30 improves long-term outcomes and reduces the costs of type 2 diabetes in Saudi Arabia

Journal of Medical Economics ◽

10.3111/13696990802589122 ◽

2008 ◽

Vol 11 (4) ◽

pp. 651-670 ◽

Author(s):

Mohammed Ali ◽

Jeremy White ◽

Chen-Hui Lee ◽

James L Palmer ◽

Jayne Smith-Palmer ◽

...

Keyword(s):

Type 2 Diabetes ◽

Saudi Arabia ◽

Insulin Aspart ◽

Long Term Outcomes ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30

Download Full-text

Three different premixed combinations of biphasic insulin aspart - comparison of the efficacy and safety in a randomized controlled clinical trial in subjects with type 2 diabetes

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2009.01035.x ◽

2009 ◽

Vol 11 (7) ◽

pp. 700-708 ◽

Author(s):

D. Cucinotta ◽

O. Smirnova ◽

J. S. Christiansen ◽

K. Kanc ◽

C. le Devehat ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Insulin Aspart ◽

Controlled Clinical Trial ◽

Efficacy And Safety ◽

Randomized Controlled Clinical Trial ◽

Randomized Controlled ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin

Download Full-text

A randomized, open-label, multicentre, parallel-controlled study comparing the efficacy and safety of biphasic insulin aspart 30 plus metformin with biphasic insulin aspart 30 monotherapy for type 2 diabetes patients inadequately controlled with oral anti

Diabetes Obesity and Metabolism ◽

10.1111/dom.13454 ◽

2018 ◽

Vol 20 (12) ◽

pp. 2740-2747

Author(s):

Lixin Guo ◽

Li Chen ◽

Baocheng Chang ◽

Liyong Yang ◽

Yu Liu ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Aspart ◽

Controlled Study ◽

Efficacy And Safety ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Diabetes Patients

Download Full-text

PDB20 BIPHASIC INSULIN ASPART 30 VERSUS ORAL HYPOGLYCEMIC AGENTS IN THE TREATMENT OF TYPE-2 DIABETES: LONG-TERM PROJECTION OF CLINICAL AND COST OUTCOMES IN SWEDEN

Value in Health ◽

10.1016/s1098-3015(10)67639-5 ◽

2005 ◽

Vol 8 (6) ◽

pp. A160

Author(s):

AJ Palmer ◽

M Lammert ◽

WJ Valentine ◽

JA Ray ◽

AS Brandt ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Aspart ◽

Hypoglycemic Agents ◽

Oral Hypoglycemic Agents ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Download Full-text

Short And Long-Term Cost-Effectiveness Of Starting Biphasic Insulin Aspart 30 In Insulin-Naïve People With Type-2 Diabetes

Value in Health ◽

10.1016/j.jval.2013.03.821 ◽

2013 ◽

Vol 16 (3) ◽

pp. A164

Author(s):

P.D. Home ◽

P. Soewondo ◽

Z. Hussein ◽

A.A. Shafie ◽

K. AlRaddady ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Short And Long Term

Download Full-text

PDB4 LONG-TERM OUTCOMES OF SWITCHING PATIENTS WITH TYPE 2 DIABETES FROM BIPHASIC INSULIN TO BIPHASIC INSULIN ASPART 30/70: AN IMPROVE STUDY SUBGROUP ANALYSIS

Value in Health ◽

10.1016/s1098-3015(10)74982-2 ◽

2009 ◽

Vol 12 (7) ◽

pp. A402

Author(s):

R Ligthelm ◽

TE Christensen ◽

TL Thomsen ◽

W Yang

Keyword(s):

Type 2 Diabetes ◽

Subgroup Analysis ◽

Insulin Aspart ◽

Long Term Outcomes ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30

Download Full-text

An analysis of the short- and long-term cost-effectiveness of starting biphasic insulin aspart 30 in insulin-naïve people with poorly controlled type 2 diabetes

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2014.08.024 ◽

2014 ◽

Vol 106 (2) ◽

pp. 319-327 ◽

Author(s):

Asrul Akmal Shafie ◽

Vishal Gupta ◽

Ranya Baabbad ◽

Eva Hammerby ◽

Philip Home

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Short And Long Term

Download Full-text

Efficacy and safety of biphasic insulin aspart and biphasic insulin lispro mix in patients with type 2 diabetes: A review of the literature

Indian Journal of Endocrinology and Metabolism ◽

10.4103/2230-8210.179993 ◽

2016 ◽

Vol 20 (3) ◽

pp. 288 ◽

Author(s):

Ajay Kumar

Keyword(s):

Type 2 Diabetes ◽

Insulin Lispro ◽

Insulin Aspart ◽

Efficacy And Safety ◽

Review Of The Literature ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin

Download Full-text

Efficacy and Safety of Biphasic Insulin Aspart 30/70 in Type 2 Diabetes Suboptimally Controlled on Oral Antidiabetic Therapy in Korea: A Multicenter, Open-Label, Single-Arm Study

Diabetes & Metabolism Journal ◽

10.4093/dmj.2013.37.2.117 ◽

2013 ◽

Vol 37 (2) ◽

pp. 117 ◽

Author(s):

Kee-Ho Song ◽

Jung Min Kim ◽

Jung-Hyun Noh ◽

Yongsoo Park ◽

Hyun-Shik Son ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Aspart ◽

Efficacy And Safety ◽

Antidiabetic Therapy ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Oral Antidiabetic ◽

Biphasic Insulin Aspart 30

Download Full-text

Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea

Current Medical Research and Opinion ◽

10.1185/03007990802597951 ◽

2008 ◽

Vol 25 (1) ◽

pp. 65-75 ◽

Author(s):

Richard Bergenstal ◽

Andrew Lewin ◽

Timothy Bailey ◽

Denise Chang ◽

Titus Gylvin ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Insulin Aspart ◽

Efficacy And Safety ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin

Download Full-text